CBT and combined rehabilitation offer moderate benefits for long COVID, enhancing quality of life and reducing fatigue, but evidence quality is variable.
Keytruda’s cervical cancer data; Arcutis’ offering; Alaya.bio announces a CAR-T deal
Keytruda’s positive cervical cancer data: Merck said Friday that its powerhouse cancer drug reduced the risk of disease progression or death in advanced cervical cancer